---
title: "Alaunos Therapeutics (TCRT) Stock Soars Over 29% After-Hours: Here's What's Going On"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/299408019.md"
description: "Alaunos Therapeutics (TCRT) shares surged over 29% in after-hours trading following the adoption of new bylaws that lower the quorum requirement for stockholder meetings from a majority to one-third of outstanding voting shares. This change aims to facilitate future corporate actions, such as financings or mergers, by making it easier to achieve the threshold for shareholder votes."
datetime: "2026-09-18T06:30:36.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/299408019.md)
  - [en](https://longbridge.com/en/news/299408019.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/299408019.md)
generator: "portal-rs"
---

# Alaunos Therapeutics (TCRT) Stock Soars Over 29% After-Hours: Here's What's Going On

**Alaunos Therapeutics Inc.** (NASDAQ:TCRT) shares climbed 29.28% to $2.07 after the bell on Thursday following a **Securities and Exchange Commission** filing that showed the company approved and adopted its Second Amended and Restated By-Laws, effective immediately.

## **Bylaws Overhaul Lowers the Bar for Shareholder Votes**

According to the filing, the adoption happened on Wednesday. 

The new bylaws amend and restate the company’s prior Amended and Restated By-Laws, which had been adopted Jan. 8. Under this change, the quorum required for stockholder meetings drops to one-third of outstanding voting shares, down from a prior majority standard. The quorum needed for board and committee meetings remains a majority, unchanged from before.

For this, the Fort Lauderdale-based clinical-stage biotech’s board revised Article 2, Section 2.8 of its bylaws to make this change. 

 **Read Also: Why Is BlackBerry (BB) Stock Trending After Hours** 

## **Why the Market Is Reacting**

A lower quorum bar makes it structurally easier for Alaunos to hit the threshold required to conduct official stockholder votes.

**Benzinga’s Take:** This could smooth the path for future corporate actions, including financings, mergers, or other strategic votes requiring shareholder approval.

## Trading Metrics, Technical Analysis

Alaunos has a market capitalization of approximately $4.06 million. Its stock has traded between a 52-week high of $4.59 and a 52-week low of $1.28.

TCRT has a Relative Strength Index (RSI) of 46.07.

Over the past 12 months, the small-cap stock has fallen 36%.

TCRT is currently positioned at about 9.7% of its 52-week range.

**Price Action:** The biotech stock closed Thursday’s regular session at $1.60, up 25%, according to Benzinga Pro data.

 **See More: Top Value Stocks** 

***Disclaimer:*** *This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.*

*Photo Courtesy: Ksw Photographer on Shutterstock.com*

### Related Stocks

- [TCRT.US](https://longbridge.com/en/quote/TCRT.US.md)
- [BB.US](https://longbridge.com/en/quote/BB.US.md)

## Related News & Research

- [Alaunos Therapeutics cuts stockholder meeting quorum requirement to one-third from majority](https://longbridge.com/en/news/299300336.md)
- [Alaunos Therapeutics Announces New Registered Direct Offering](https://longbridge.com/en/news/299813835.md)
- [Seagate vs. Western Digital vs. Toshiba: The AI Storage War Is Getting Serious](https://longbridge.com/en/news/301054654.md)
- [History Says Infrastructure Booms Create Winners and Losers. Here Are 3 AI Cloud Stocks to Watch.](https://longbridge.com/en/news/301060298.md)
- [Personalis-Tempus AI deal clears US antitrust waiting period under HSR Act](https://longbridge.com/en/news/301072040.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**